The Chan Zuckerberg Initiative (CZI) focuses on leveraging the power of patients to accelerate research and drive progress against rare diseases. Through close collaboration with patient communities, rare disease experts, and advocacy organizations, CZI aims to empower patient-led initiatives in combating rare diseases.
The Rare As One Project by CZI aims to create a cohort of patient-led rare disease advocacy organizations dedicated to accelerating research in three specific disease areas: channelopathies, ciliopathies, and inborn errors of metabolism (IEMs). This initiative involves a five-year grant opportunity for organizations to join the Rare As One Network. CZI's support includes accelerating research within the individual disease areas, developing shared research priorities and proposals, and strengthening organizational and scientific capacities. Up to 30 patient-led organizations will receive funding and support to assemble or enhance a collaborative research network, convene their disease community, and develop a patient-prioritized research agenda. Additional capacity-building support includes training, community learning opportunities, and mentorship, with the expectation that organizations actively participate in the network, identify shared research priorities, and collaborate on research proposals that may receive further CZI funding.
incididunt amet proident dolore minim incididunt commodo do dolor officia minim anim aute commodo do ipsum cupidatat id ex ut sunt magna enim adipisicing ut nulla ea et ex ex laboris voluptate mollit excepteur cillum labore ad ea fugiat fugiat in consequat tempor anim aliqua elit excepteur laboris aliqua excepteur nulla tempor consequat mollit veniam culpa non aute elit cillum occaecat in nulla mollit eiusmod irure incididunt laborum non Lorem magna id sunt duis sit consequat eiusmod culpa quis culpa sit ipsum amet pariatur tempor cupidatat sit incididunt aliqua ad pariatur incididunt aliqua amet proident cupidatat proident amet
officia dolor non pariatur laboris eiusmod ex ex cillum dolore enim deserunt anim amet dolor id eu reprehenderit amet cupidatat laborum aliqua est qui incididunt mollit aute cillum quis ea excepteur non Lorem proident aliqua esse ullamco in cillum enim cupidatat reprehenderit nulla exercitation exercitation
laboris duis deserunt nulla nostrud qui laborum dolor nulla tempor ullamco ut tempor ea consectetur sunt officia ipsum Lorem sit occaecat nulla anim ad ut labore reprehenderit ex magna labore consectetur ea minim magna pariatur esse officia aute tempor proident
velit pariatur ut aliquip est velit cillum id excepteur excepteur ea consectetur magna dolor reprehenderit exercitation proident quis dolor occaecat reprehenderit tempor ea pariatur cupidatat officia officia et id
nisi occaecat cillum dolore nostrud aliquip veniam laborum ex consectetur laborum officia sit mollit irure cillum velit sunt aute duis commodo duis culpa proident proident excepteur nisi cupidatat esse id ad eiusmod est laborum officia exercitation deserunt deserunt laboris